Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 8/12/2019
SIETES contiene 92850 citas

 
 
 1 a 20 de 52 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Azzouz B, Morel A, Kanagaratman L, Herlem E, Trenque T. Psoriasis after exposure to angiotensin-converting enzyme inhibitors: French pharmacovigilance data and review of the literature. Drug Saf 2019;42:diciembre. [Ref.ID 103209]
2.Enlace a cita original Cita con resumen
Desai RJ, Sarpatwari A, Dejene S, Khan NF, Lii J, Rogers JR, Dutcher SK, Raofi S, Bohn J, Connolly JG, Fischer MA, Kesselheim AS, Gagne JJ. Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims. PLOS Medicine 2019:13 de marzo. [Ref.ID 103076]
3.Tiene citas relacionadas
Weber MA, Bakris GL, Weir MR, Jamerson K. Obesity, blood pressure, and cardiovascular outcomes - Authors' reply. Lancet 2013;381:1982. [Ref.ID 95608]
4.Tiene citas relacionadas
Dong S, Mao B. Obesity, blood pressure, and cardiovascular outcomes. Lancet 2013;381:1982. [Ref.ID 95607]
5.Tiene citas relacionadas
Blankfield RP. Obesity, blood pressure, and cardiovascular outcomes. Lancet 2013;381:1981. [Ref.ID 95606]
6.Tiene citas relacionadas
Barrios V, Escobar C. Obesity, blood pressure, and cardiovascular outcomes. Lancet 2013;381:1981. [Ref.ID 95605]
7.Tiene citas relacionadas
Elijovich F, Laffer C. Obesity, blood pressure, and cardiovascular outcomes. Lancet 2013;381:1981. [Ref.ID 95604]
8.Tiene citas relacionadas Cita con resumen
Weber MA, Jamerson KB, Bakris GL, Weir MR, Zappe D, Zhang Y, Dahlof B, Velázquez EJ, Pitt B. Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial. Lancet 2013;381:537-45. [Ref.ID 94952]
9.Tiene citas relacionadas
Messerli FH, Bangalore S. Diuretic-based regimens for obese patients?. Lancet 2013;381:512-3. [Ref.ID 94951]
10.Tiene citas relacionadas Cita con resumen
Bakris GL, Sarafidis PA, Weir MR, Dahlöf B, Pitt B, Jamerson K, Velázquez EJ, Staikos-Byrne L, Kelly RY, Shi V, Chiang Y-T, Weber MA, for the ACCOMPLISH trial investigators. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial. Lancet 2010;375:1173-81. [Ref.ID 88236]
11.Tiene citas relacionadas Cita con resumen
Heerspink HL, de Zeeuw D. Composite renal endpoints: was ACCOMPLISH accomplished?. Lancet 2010;375:11401142. [Ref.ID 88229]
12.Enlace a cita original Cita con resumen
Chobanian AV. The hypertension paradox - More uncontrolled disease despite improved therapy. N Engl J Med 2009;361:878-87. [Ref.ID 86658]
13. Cita con resumen
Sink KM, Leng X, Williamson J, Kritchevsky SB, Yaffe K, Kuller L, Yasar S, Atkinson H, Robbins M, Psaty B, Golf Jr DC. Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension. Results from the Cardiovascular Health Study. Arch Intern Med 2009;169:1195-202. [Ref.ID 86332]
14.Tiene citas relacionadas
Jamerson K, Weber MA. Benazepril plus amlodipine or hydrochlorothiazide for hypertension. The authors reply. N Engl J Med 2009;360:1149-50. [Ref.ID 85448]
15.Tiene citas relacionadas
Davis BR, Whelton PK, for the ALLHAT Collaborative Research Group. Benazepril plus amlodipine or hydrochlorothiazide for hypertension. N Engl J Med 2009;360:1148-9. [Ref.ID 85447]
16.Tiene citas relacionadas
Strauss MH, Weinstein J, Newton GE. Benazepril plus amlodipine or hydrochlorothiazide for hypertension. N Engl J Med 2009;360:1148. [Ref.ID 85446]
17.Tiene citas relacionadas
Parra D, Rosenstein R. Benazepril plus amlodipine or hydrochlorothiazide for hypertension. N Engl J Med 2009;360:1147-8. [Ref.ID 85445]
18.Tiene citas relacionadas Cita con resumen
Chobanian AV. Does it matter how hypertension is controlled?. N Engl J Med 2008;359:2485-8. [Ref.ID 84604]
19.Tiene citas relacionadas Cita con resumen
Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V, Gupte J, Gatlin M, Velázquez EJ, for the ACCOMPLISH trial investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008;359:2417-8. [Ref.ID 84603]
20. Cita con resumen
Anónimo. 2007 US pharma woes to dog Novartis growth until late 2008. Scrip 2008;3329:7. [Ref.ID 82030]
Seleccionar todas
 
 1 a 20 de 52 siguiente >>